The emerging treatment of the medication represents a major development in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 https://tirzepatide-peptide678209.win-blog.com/23334224/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment